Skip to main content

Stem Cell Therapy for Autism in Istanbul: A Family Guide

What research is investigating, how our medical team assesses a child or adult, and what a case review and treatment plan involve for your family.

Understanding Autism Spectrum Disorder (ASD)

Autism is a lifelong neurodevelopmental difference, and every autistic person has their own profile of communication, sensory, learning and health needs. Families who contact our clinic are usually looking for support with the parts of daily life that are hardest right now - communication, attention, sensory regulation, sleep, or digestive comfort - not for a different child.

Where regenerative medicine is directed in autism is biology that sits alongside development rather than development itself. Two threads run through the research. One is immune and inflammatory activity, which differs measurably in some autistic people; the other is the signals cells release to influence their neighbours, called paracrine signalling. Mesenchymal stromal cells are studied for both, and particularly for immunomodulation - their influence on how immune and inflammatory cells behave. The cells our program works with come from Wharton's jelly, the soft gelatinous tissue inside a donated umbilical cord, collected after a healthy birth with written maternal consent from tissue that would otherwise be discarded. This work is early, and our team will describe what is being investigated without predicting how one child will respond.

A case review starts with the diagnostic report, developmental history, any genetic or metabolic testing, sleep and gastrointestinal symptoms, seizure history and current medication. Speech and language therapy, occupational therapy, educational and behavioural support all continue exactly as they are; nothing in a plan is a substitute for them. Where treatment is appropriate, the areas a family hopes to support are written down as goals beforehand, so that changes over the following months are observed carefully rather than assumed. Families are welcome to start with a case review of their child's records, long before any conversation about travelling.

How Autism Spectrum Disorder (ASD) Can Affect Daily Life

Symptoms, severity and progression vary from person to person. Our medical team uses this kind of detail as context for your case review; it is not a diagnostic checklist. Diagnosis, and any change in your symptoms, belong with the clinician who knows your medical history.

  • Different patterns of spoken communication, language development, or AAC use
  • Differences in eye contact, social communication, and relationship patterns
  • Sensory sensitivities to sound, light, touch, food or textures
  • Repetitive behaviours, stimming or strong dependence on routines
  • Individual attention, focus, movement, and regulation needs
  • Sleep, gastrointestinal, feeding, or other co-occurring health needs

Illustrated guide

One spectrum, many individual contexts

Autism is a lifelong neurodevelopmental spectrum, and no two profiles of communication, sensory experience, health, and support needs look the same. The insets show the administration routes families most often ask us about.

Nested editorial illustration of neurodevelopmental connectivity with intravenous, intrathecal, and intranasal administration route insets for autism research discussions
An illustration of neurodevelopmental diversity alongside the intravenous, intrathecal, and intranasal routes discussed in autism research. It is drawn for explanation, not photographed from a patient or a procedure.

What the visual brings together

  1. Neurodevelopmental diversity

    Communication, sensory processing, learning, movement, sleep, and co-occurring health needs vary widely between autistic people.

  2. Intravenous route

    An infusion enters the bloodstream, so it is considered and monitored systemically rather than as a local procedure.

  3. Intrathecal route

    Lumbar administration reaches the fluid around the spinal cord and is an invasive procedure our team assesses individually.

  4. Intranasal route

    Nasal delivery is an early research route, and the formulation, dose, and evidence behind it are part of any discussion we have with you.

Why Regenerative Medicine Is Being Studied in ASD

These are the biological mechanisms researchers are investigating. A mechanism is a reason to study a treatment, not a promise of benefit for an individual patient. Our medical team will explain how much of this research applies to your own diagnosis.

  • The mechanism under study is signalling: the biological messages these cells release to influence the cells around them, known as paracrine signalling
  • Research attention centres on immune and inflammatory behaviour, known as immunomodulation, studied in a subset of autistic people
  • Areas families may hope to support include communication, attention, sensory regulation, sleep and daily routines; these are recorded as goals, never as expected results
  • Intravenous infusion and intrathecal administration differ in what they involve for a child, and our team explains the reasoning and the risks for that specific case
  • Established developmental, educational and behavioural supports continue throughout, and progress from them is credited to them
  • Research in autism is at an early stage, and our medical team will say plainly when treatment is not appropriate for a child

Research maturity

What the Research Currently Shows for ASD

How far published research has travelled for each approach, from laboratory work through to established standard care. It describes the maturity of the evidence, not how well any option works and not what to expect in an individual case.

  1. 01Laboratory and animal work
  2. 02Early human studies
  3. 03Controlled trials under way
  4. 04Established standard of care
  • Developmental, educational and behavioural support

    The support with the strongest evidence base, and the foundation any investigational option is planned around rather than in place of.

    Established standard of care

  • Cord blood or umbilical cord MSC infusion for autism

    Randomised placebo-controlled studies did not meet their primary outcomes. Research here is at an early stage, and these products are investigational rather than established autism treatments.

    Early human studies

An editorial summary of published research maturity, not a measure of benefit for an individual patient. Levels change as studies are published.How to read the evidence

The proposed mechanism, illustrated

What is being studied in the signalling in ASD

Illustration in several parts: the Bosphorus and the clinic in Istanbul, a doctor talking with a mother while her son plays beside her, and a tray of prepared syringes; then an intravenous infusion and an intranasal administration; then a macro view of neurons and their supporting cells with translucent vesicles drifting among the branching processes; and at the end a mother and her son laughing together above the water. An illustration made for this page, not footage of a patient, a procedure or a laboratory result. It shows the signalling researchers are investigating, not a change that has been demonstrated in children and not an outcome any family should expect.

Your case review

How Our Medical Team Reviews Your Case

Your review starts with the confirmed diagnosis, recent reports and imaging, current treatment, medical history, and the outcome that matters most to you. Not everyone is suitable for regenerative medicine, and our team will say so when the care you already receive is the better route.

  • A confirmed autism diagnosis, with the diagnostic report, developmental history and any genetic or metabolic results
  • A review of the supports already in place - speech and language, occupational therapy, education, behavioural and medical care
  • Sleep, feeding, gastrointestinal and seizure history, each of which affects both suitability and safety
  • A full medication and supplement list, reviewed by our medical team for interactions
  • Consent from a parent or guardian, with assent from the child or adult wherever that is possible
  • Goals written down with the family before treatment, in the areas they most want to support

How Treatment for ASD Is Planned at Our Istanbul Clinic

The path international patients follow with us, from the first review of your records to follow-up after you return home. The exact steps depend on what your medical review finds.

Send your medical records

Recent reports, imaging, your current medication, and what you hope treatment will help with. It lets our medical team make the review specific to you.

Start your case review
  1. Send your medical records

    Your case review starts with the confirmed diagnosis, recent reports and imaging, current medications, previous procedures and the outcomes that matter most to you. Everything can be sent digitally from home, long before travel is discussed.

  2. Case review by our medical team

    Our medical team reads the file against your diagnosis, disease stage, imaging, laboratory results, current treatment and any contraindications, then decides whether regenerative medicine is appropriate for you and which goals are realistic to discuss.

  3. Your written treatment plan

    When treatment is appropriate, you receive the plan in writing: the cell material and how it is prepared, the dose, the route of administration, the number of sessions, the monitoring involved and an itemized cost with no assumed extras.

  4. Your treatment in Istanbul

    On arrival our team repeats the checks that matter for your case, confirms the plan with you, and carries out treatment under medical supervision with an observation period afterwards. Your coordinator handles scheduling, timings and what each day involves.

  5. Follow-up and monitoring

    Before you fly home we agree what will be measured, when it will be reviewed and how to reach us. Follow-up continues remotely and can be shared with your own doctors, so your treatment plan and your local care stay aligned.

Your treatment plan

What Our Medical Team Explains Before You Decide

"Stem cells" and "exosomes" name a category, not a specific product. What matters in your plan is the source of the material, how it was prepared, the route and the dose, the clinical setting, and why you were considered suitable. Our medical team sets each of those out for the treatment being proposed to you.

We plan treatment alongside the care you already receive, so keep your own clinician involved and record a clear baseline before you travel. For the practical side, read the Istanbul treatment trip guide and the cost guide, then ask us for an itemized estimate.

  1. Which published research applies to your diagnosis and to the route we propose.
  2. Where the biological material comes from, how it is prepared, and how it is documented.
  3. The possible side effects and the contraindications that apply to your procedure.
  4. Which functional outcome is measured before treatment and again at follow-up.
  5. How treatment sits alongside your existing care, including the option of not treating.
  6. Who to contact about follow-up, or about a complication, once you are home.
  7. What your estimate includes and excludes, and what is due before you travel.

Next step

Start with a medical case review

Send your diagnosis, recent reports, imaging and current medication, and tell us what you want treatment to help with.

Request a Medical Case Review

Autism Spectrum Disorder (ASD): Questions Patients Ask Us

What does stem cell therapy for autism cost in Istanbul, Turkey?

Dose for a child is calculated by weight, so a quote is specific to that child and cannot be compared with an adult's. Our patient coordination team itemizes the medical review, the number of sessions, the route, any sedation and the monitoring involved, and states clearly what the figure does not include.

Which route of administration is used for autism at your clinic?

Intravenous infusion and intrathecal administration are the routes discussed in this research, and they differ greatly in what a child experiences. Our medical team recommends one based on age, weight, medical history, sedation risk and how the child copes with procedures, and explains the specific risks before you decide anything.

How are changes assessed after treatment?

By agreeing in advance what to watch. Goals are recorded with the family - words used, attention span, sensory tolerance, sleep pattern, feeding, daily routines - and reviewed at set points with our team. Where the child's own therapists use structured assessments, those results are the most useful evidence of all, which is why their work continues throughout.

Can autistic adults be considered, not only children?

Yes. Adults are assessed on the same basis: diagnosis, medical history, medication, co-occurring health needs, and goals defined by the person themselves wherever possible. Communication preferences and sensory needs are planned into the visit itself, including quieter appointment times where that helps.

How soon would a family notice anything?

We do not offer a timetable, because that would be a promise about something research has not settled. What we do offer is structure: written goals, agreed review points, and an honest conversation at each one about what has changed, what has not, and whether anything further is reasonable.

Are Wharton's jelly stem cells used to treat Autism Spectrum Disorder (ASD) in Istanbul?

Yes. Our regenerative medicine program works with mesenchymal stromal cells (MSCs) grown from Wharton's jelly, the gelatinous tissue inside the umbilical cord. It is donated after a healthy birth with written maternal consent, from tissue that would otherwise be discarded, so nothing is taken from mother or baby and none of the ethical questions attached to embryonic sources arise. Because these cells expand readily in culture, a batch is characterised and release-tested before it reaches anyone. Your written plan names the material, how it is prepared, the dose, the route of administration and the schedule, and our medical team explains why each of those was chosen for your case.

Why use donor cells from Wharton's jelly rather than my own cells for Autism Spectrum Disorder (ASD)?

Wharton's jelly is a young, perinatal tissue rather than an adult one, so the starting material does not carry the age or the health history of the person being treated, and nothing has to be harvested from you on the day. These cells also have a low-immunogenicity profile, which is why this source is studied for use between unrelated people. Most of all, they are strong secretors: the signalling molecules MSCs release are the mechanism most current research centres on, and that is what a plan is built around.

How long do international patients stay in Istanbul for Autism Spectrum Disorder (ASD) treatment?

The length of stay follows your plan: the route of administration, the number of sessions, the monitoring after each one, and any mobility or assistance you need. Our patient coordination team confirms appointment dates, daily timings and the expected length of the visit in writing before you book flights.

Is stem cell therapy for Autism Spectrum Disorder (ASD) safe?

No medical procedure is free of risk. Our medical team screens for infection, bleeding risk, medication interactions and other contraindications before treatment, explains the risks specific to the route used in your plan, and monitors you during administration and afterwards. If something makes treatment unsafe for you, we say so instead of proceeding.

What can stem cell therapy realistically aim for in Autism Spectrum Disorder (ASD)?

Goals are set with you and described as aims, not results. Regenerative medicine treatments are planned individually, responses vary between patients and no clinical outcome can be guaranteed. Your plan states what will be measured, when it will be reviewed, and how treatment sits alongside the care you already receive.

How do I start a Autism Spectrum Disorder (ASD) case review from outside Turkey?

Send your confirmed diagnosis, recent reports and imaging, your current medication list, previous procedures and the goals that matter to you. Our medical team reviews them remotely and comes back with an assessment of whether treatment in Istanbul is appropriate for your case, and what the next step would be.

Medical Disclaimer: Information on this page is educational and is not personal medical advice. Regenerative medicine treatments are planned individually, responses vary and no clinical outcome can be guaranteed. Some of the approaches described remain investigational. Suitability is confirmed only after medical review, and treatment is planned alongside your existing care.

Wide sunrise view from Istanbul's Asian shore with a ferry and the historic peninsula across the water

Sunrise from Istanbul's Asian shore, looking across the water. It shows the city you would travel to, not our clinic, your accommodation, or a service included in a plan.

Build support into your Istanbul plan for ASD

Our patient coordination team works through medication timing, mobility or sensory support, rest between appointments, transfers, and follow-up with you before you book travel for ASD.

More from our clinic

Planning treatment for ASD in Istanbul

The practical side of treatment at our clinic: what the research shows, who may be suitable, what a plan costs, and how your stay in Istanbul and your follow-up are arranged.

Cost, Outcomes & Istanbul

International patient support

Ask our medical team about treatment for Autism Spectrum Disorder (ASD).

Send your diagnosis, recent reports, imaging and current medication. Our medical team reviews them and explains which regenerative medicine options may fit your case, and what treatment in Istanbul would involve.

Your review starts from home

Nothing needs to be booked to begin. Our patient coordination team plans your visit to Istanbul once your treatment plan is agreed.